These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 7073083

  • 1. Chemotaxis of horse polymorphonuclear leukocytes to N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Zinkl JG, Brown PD.
    Am J Vet Res; 1982 Apr; 43(4):613-6. PubMed ID: 7073083
    [Abstract] [Full Text] [Related]

  • 2. Chemokinetic activity of N-formyl-methionyl-leucyl-phenylalanine on human neutrophils, and its modulation by phenylbutazone.
    Perianin A, Labro MT, Hakim J.
    Biochem Pharmacol; 1982 Oct 01; 31(19):3071-6. PubMed ID: 6756410
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
    Cotter TG, Keeling PJ, Henson PM.
    J Immunol; 1981 Dec 01; 127(6):2241-5. PubMed ID: 7053244
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antagonists of the formylated peptide chemoattractants: structure-activity comparisons with formyl-methionyl-leucyl-phenylalanine-OH.
    Freer RJ, Day AR, Muthukumaraswamy N, Showell HJ, Becker EL.
    Kroc Found Ser; 1981 Dec 01; 14():161-8. PubMed ID: 6947071
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
    Charo IF, Yuen C, Perez HD, Goldstein IM.
    J Immunol; 1986 May 01; 136(9):3412-9. PubMed ID: 3514759
    [Abstract] [Full Text] [Related]

  • 14. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
    Fletcher MP.
    J Immunol; 1986 Jun 01; 136(11):4213-9. PubMed ID: 3009618
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I, Kawasaki M, Matsuda A, Kataoka M, Kokurba Y.
    Arzneimittelforschung; 1998 Dec 01; 48(12):1163-7. PubMed ID: 9893931
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H, Gallin JI.
    J Immunol; 1981 Sep 01; 127(3):839-44. PubMed ID: 6790618
    [Abstract] [Full Text] [Related]

  • 19. Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine.
    Anderson DC, Hughes BJ, Smith CW.
    J Clin Invest; 1981 Oct 01; 68(4):863-74. PubMed ID: 7287906
    [Abstract] [Full Text] [Related]

  • 20. Stimulus- and cumulative dose-dependent inhibition of O2- production by polymorphonuclear leukocytes of patients receiving corticosteroids.
    Fukushima K, Ando M, Ito K, Suga M, Araki S.
    J Clin Lab Immunol; 1990 Nov 01; 33(3):117-23. PubMed ID: 1967000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.